TECH
Biotechnology · Healthcare
Analyst
on behalf of Dan Brennan)
Analyst
TD Cowen
Analyst
covering for Dan Brennan)
Analyst
on behalf of Doug Schenkel)
Equibles does not estimate personal net worth.
Kyle Boucher is recorded as Analyst at on behalf of Dan Brennan), Analyst at TD Cowen, Analyst at covering for Dan Brennan) and Analyst at on behalf of Doug Schenkel). Kyle Boucher has spoken on 1 earnings call across 1 company, most recently for BIO-TECHNE Corp on May 6, 2026. The companies whose calls Kyle Boucher spoke on are classified in the Healthcare sector.
“I knew you touched on this a little bit, but I wanted to ask another, just a clarification question on the guide. You said flat organic in fiscal Q4, sort of implying low single-digit underlying growth, excluding the GMP headwinds, but it sounds like there's fewer sort of discrete items in the fiscal fourth quarter.”
on behalf of Dan Brennan)
Analyst
Source not stated
TD Cowen
Analyst
Source not stated
covering for Dan Brennan)
Analyst
Source not stated
on behalf of Doug Schenkel)
Analyst
Transcript header (unverified)
TECH
Biotechnology · Healthcare